View Older Stories View More Recent Stories

Feb 10, 2020 08:28AM Citius Pharmaceuticals to Present at Noble Capital Markets' 16th Annual Investor Conference
Feb 4, 2020 08:00AM Citius Achieves 50% Patient Enrollment in Phase 3 Mino-Lok® Pivotal Trial
Feb 3, 2020 08:03AM Citius Pharmaceuticals (CTXR) Regains Compliance with Nasdaq Listing Requirements
Feb 3, 2020 08:00AM Citius Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements
Jan 24, 2020 07:23AM Citius Pharmaceuticals (CTXR) PT Raised to $4 at H.C. Wainwright
Dec 19, 2019 08:27AM Citius Pharmaceuticals (CTXR) to Resume Trading at 8:30 am
Dec 19, 2019 08:27AM Citius Pharmaceuticals (CTXR) Announces Positive Outcome of Interim Futility Analysis for its Phase 3 Mino-Lok Pivotal Trial
Dec 19, 2019 08:00AM Citius Announces Positive Outcome of Interim Futility Analysis for its Phase 3 Mino-Lok® Pivotal Trial
Dec 19, 2019 07:55AM Citius Pharmaceuticals (CTXR) Halted, News Pending
Dec 4, 2019 08:00AM Citius Pharmaceuticals to Present at the 12th Annual LD Micro Main Event
Nov 8, 2019 08:00AM Citius Pharmaceuticals Issues Corporate Update
Oct 24, 2019 08:00AM Citius Pharmaceuticals to Present at the 5th Annual Dawson James Small Cap Growth Conference
Oct 15, 2019 08:00AM Citius Pharmaceuticals to Present at the MicroCap Rodeo
Oct 7, 2019 08:30AM Citius Reaches First Interim Analysis Milestone for Mino-Lok® Pivotal Trial
Oct 3, 2019 07:00AM Citius Provides Update on Activities From IDWeek 2019
Sep 27, 2019 11:28AM Citius Announces Closing of $7.0 Million Underwritten Offering Priced At-the-Market
Sep 25, 2019 07:03AM Citius Pharmaceuticals (CTXR) Prices $7 Million Underwritten Offering Priced At-the-Market of Common Stock, Warrants
Sep 25, 2019 07:00AM Citius Announces Pricing of $7.0 Million Underwritten Offering Priced At-the-Market
Sep 4, 2019 06:58AM Citius Pharmaceuticals (CTXR) Announces Change to Primary Endpoint In Mino-Lok Phase 3 Study
Sep 4, 2019 06:55AM Citius Announces Change To Primary Endpoint In Mino-Lok® Phase 3 Study
Aug 29, 2019 08:00AM Citius Pharmaceuticals, Inc. to Present at the RHK Capital 4th annual Disruptive Growth Conference hosted by Reed Smith.
Aug 22, 2019 07:13AM Citius Pharmaceuticals (CTXR) PT Lowered to $1.65 at H.C. Wainwright
Jul 30, 2019 08:00AM Citius Provides Developmental Plans for Mino-Wrap
May 13, 2019 08:47AM Citius Pharmaceuticals' Mino-Lok® Highly Efficacious in Rapidly Eradicating Candida auris
May 1, 2019 08:00AM Citius Pharmaceuticals to Present at the ThinkEquity Conference
Apr 30, 2019 09:45AM Citius Pharmaceuticals Presents Data on Mino-Lok® Showing 98% Clinical Efficacy
Apr 4, 2019 08:30AM Citius Pharmaceuticals Successfully Raises $5.3 Million
Apr 1, 2019 09:03AM Citius Pharmaceuticals (CTXR) Announces $5.3 Million Registered Direct Offering of Common Stock Priced At-the-Market
Apr 1, 2019 09:00AM Citius Announces $5.3 Million Registered Direct Offering Priced At-the-Market
Feb 6, 2019 01:11PM Citius Provides Update on Its CITI Platforms and Gives Investors Further Insight on their Licensing Agreement with MD Anderson Cancer Center
Jan 25, 2019 08:00AM Citius Pharmaceuticals to Present at NobleCon15 Investor Conference
Jan 8, 2019 09:00AM Citius Licenses Mino-Wrap From MD Anderson Cancer Center
Jan 4, 2019 10:45AM Citius Pharmaceuticals to Present at Biotech Showcase Investor Conference
Dec 19, 2018 09:52AM Citius Pharmaceuticals (CTXR) Reports Update on Mino-Lok and CITI-002
Dec 19, 2018 09:45AM Citius Pharmaceuticals Provides Updates on Mino-Lok® and CITI-002
Nov 30, 2018 08:00AM Citius Pharmaceuticals to Present at the 11th Annual LD Micro Main Event
Oct 25, 2018 08:00AM Citius Pharmaceuticals to Present at Dawson James Securities 4th Annual Small Cap Growth Conference
Oct 23, 2018 08:00AM Citius Reports On Activities During Infectious Disease Week 2018
Sep 27, 2018 08:00AM Citius Announces The Publication Of European Patent For Mino-Lok®
Sep 25, 2018 08:00AM Citius Announces The Issuance Of The Patent On The Advanced Stability Of Mino-Lok® By USPTO
Aug 15, 2018 08:00AM Citius Pharmaceuticals Successfully Raises $10 Million
Aug 13, 2018 05:00PM Citius Announces Closing of $10.0 Million Underwritten Offering Priced At-the-Market
Aug 9, 2018 06:23AM Citius Pharmaceuticals (CTXR) Prices 7.843M Share Offering at Approx. $10M
Aug 9, 2018 06:00AM Citius Announces Pricing of $10.0 Million Underwritten Offering Priced At-the-Market
Jul 24, 2018 08:04AM Citius Pharmaceuticals (CTXR) Granted Notice Of Allowance from USPTO on Advanced Stability Patent Application For Mino-Lok
Jul 24, 2018 08:00AM Citius Announces The Notice Of Allowance From The USPTO On The Advanced Stability Patent Application For Mino-Lok®
Jul 13, 2018 10:48AM Citius Announces Key Addition to its Scientific Advisory Board
Jul 9, 2018 08:10AM Citius Pharmaceuticals (CTXR) Announces Clinical Update And Progress of Mino-Lok Phase 3 Trial
Jul 9, 2018 08:00AM Citius Provides Clinical Update And Progress Of The Mino-Lok® Phase 3 Trial
Jun 19, 2018 08:00AM Citius Announces United States Patent & Trademark Office Registered the Company's Mino-Lok® Trademark
View More Recent Stories View Older Stories